Meridian Subsidiary Bioline, Launches ISOLATE II

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. VIVO, is proud to announce the worldwide release of the high performance ISOLATE II range of nucleic acid purification kits. Based on filter membrane spin column technology with simple bind-wash-elute steps; the new Bioline ISOLATE II kits are designed for fast and efficient isolation of DNA or RNA from a wide range of biological materials. By using ISOLATE II kits, researchers can expect higher yields, higher purity and greater reproducibility when compared to previous generation nucleic acid purification kits. Marco Calzavara, President of Bioline commented, “With ISOLATE II nucleic acid purification kits, researchers can now quickly achieve See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidanceManagement
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!